Twist Bioscience

Twist Bioscience

Biotechnology Research

South San Francisco, California 130,089 followers

Synthetic DNA for Health & Sustainability

About us

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. Twitter @TwistBioscience Facebook facebook.com/TwistBioscience YouTube youtube.com/TwistBioscience #WeMakeDNA

Website
https://www.twistbioscience.com
Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
South San Francisco, California
Type
Public Company
Founded
2013
Specialties
Synthetic Biology, DNA, Biotechnology, Drug Discovery, Gene Synthesis, Primers, NGS, Oligonucleotides, Life Sciences, Synthetic DNA, Next Gen Sequencing, CRISPR, DNA Data Storage, Variant Libraries, DNA Sequencing, Pharmaceutical, Exome Sequencing, Target Enrichmentt, CRISPR Libraries, and Core Exome

Locations

Employees at Twist Bioscience

Updates

  • View organization page for Twist Bioscience, graphic

    130,089 followers

    🦠 Webinar On Demand: Unveiling the Secrets of Predatory Bacteria! 🦠 Discover the fascinating world of Bdellovibrio bacteriovorus, a predatory bacterium that invades and consumes other gram-negative bacteria from within. Join us for an insightful webinar where Dr. Simon Caulton from the University of Birmingham will reveal groundbreaking research on the molecular mechanisms of this unique bacterium. Learn about the newly identified mosaic adhesive trimers (MATs) and their role in bacterial predation. 🔬 In this webinar, you will: - Understand the significance of MATs for B. bacteriovorus. - Explore how these MATs were characterized using advanced structural and biophysical techniques. - Discover why Twist Bioscience Clonal Genes were crucial for this research. - Gain insights into how predatory bacteria bind to prey cells. 📺 WATCH NOW and dive into the world of predatory bacteria: https://lnkd.in/gtRRp8AD

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    🎉 Announcing the expansion of our high-throughput antibody portfolio with the launch of a CHO cell line for Twist Express Antibodies! “With the majority of biotherapeutic drugs manufactured in CHO cell lines, expressing small-scale therapeutic antibody candidates in CHO for screening has become a vital first step to ensure successful downstream scale-up. We now provide a comprehensive portfolio of antibody production to further serve the biopharma market by offering both HEK293 with reduced turnaround times enabled by our Express Genes as well as the newly launched CHO cell line for Twist Express Antibodies,” said Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “By taking on the process of antibody development from sequence to protein, we meet the needs of therapeutic developers who currently make their own antibodies, a costly bottleneck in the discovery pipeline, providing them with a cost-effective, customizable, and scalable offering to support their research.” Twist Bioscience Expands High-throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies: https://lnkd.in/gGh8nv4r #TwistBiopharmaSolutions #antibody #DNA

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    Announcing the newest addition to our portfolio of synthetic viral controls: RNA control for H5N1 Influenza A! NGS-verified, and covering 99.9% of hemagglutinin (HA) & neuraminidase (NA) genome regions. “As agricultural and infectious disease researchers around the world continue to monitor the spread of H5N1, we continue our unwavering commitment to responding rapidly to threats to public health by providing innovative and critical tools to safeguard our global community and enable monitoring and surveillance as well as vaccine and assay development,” said Emily Leproust, CEO and co-founder of Twist Bioscience. “Our synthetic controls, including the H5N1 Influenza A control, enable broader research access without the need for live viruses. This allows critical work to be conducted in BSL-1 labs, accelerating research and development efforts. Importantly, we maintain biosecurity as a core tenet across all our products and processes. By empowering global research with safe, synthetic tools, we're advancing science while upholding the highest safety standards.” Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A: https://lnkd.in/gEsKJrVN

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    Cloned Oligo Pools now available for online ordering! It’s super easy to do here: https://lnkd.in/gbsUEqkf See how current Twist Bioscience customers are using Oligo Pools in these papers published just last week: 🧬 Bridge RNAs direct programmable recombination of target and donor DNA: https://lnkd.in/g6RwBQGE Patrick Hsu 🧬 No CRISPR: oddball ‘jumping gene’ enzyme edits genomes without breaking DNA: https://lnkd.in/gWi-G5EQ 🧬 Chromosome segregation during spermatogenesis occurs through a unique center-kinetic mechanism in holocentric moth species: https://lnkd.in/gB4JHECB 🧬 Make-or-break prime editing for bacterial genome engineering: https://lnkd.in/gVGQ2dcf Jan-Willem Veening

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    🎉 Hey iGEM Teams, Big News! 🎉 Twist Bioscience's high-quality DNA synthesis products are now available for order! As a proud sponsor of the iGEM Competition, Twist Bioscience offers exclusive benefits to support your innovative synthetic biology projects. ✨ Why Choose Twist Bioscience for iGEM?✨ 🔹 Precision Gene Fragments 🔹 Custom Oligo Pools 🔹 Special Deals Just for You! How to Get Your Hands on These Awesome Tools: 1) Head over to the Twist iGEM Sponsorship page. 2) Make sure your team is registered on the iGEM website. 3) Log in to your iGEM account and check out the sponsorship section. 4) Click through to Twist Bioscience's ordering platform and pick your products. 5) Don’t forget to use your iGEM discount codes at checkout! Let's take your iGEM project to the next level with Twist Bioscience! 🚀🧬 Questions? Visit the Twist iGEM Sponsorship page or drop us a message: https://lnkd.in/g8YW8Vtw #iGEM #TwistBioscience #SynBioRevolution #DNAGeeks #InnovateWithTwist, iGEM, iGEM Community

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    Evaluation of a targeted RNA sequencing workflow for variant calling from FFPE samples in NSCLC. In the oncology field, many research laboratories are moving beyond just interrogating the genome for mutational analysis and seeking more dynamic biomarkers. RNA-based workflows paired with analytical solutions for molecular analysis of tumor-derived samples provide a deeper understanding of tumor biology in the context of non-small cell lung cancer (NSCLC). Read all about it in our new app note: https://lnkd.in/gfDV29Nb Twist Bioscience, Koen Jacobs, Katrien De Mulder, AZ Sint-Lucas Gent

    • No alternative text description for this image
  • View organization page for Twist Bioscience, graphic

    130,089 followers

    Thank you to the incredible organizers at Biodesign Challenge for an inspiring 2024 summit. Twist Bioscience has been a proud Biodesigned sponsor for years, and this year we were thrilled to present the Outstanding Narrative Award to the Maryland Institute College of Art for ‘Symbiotic Stitches.’ The team worked with mycelium, slime mold, and lichen to create a living quilt with self regenerating properties; focusing on the concept of care as resiliency within their community. Congratulations to the Top 8 finalists, Outstanding Prize winners, and the Grand Prize winner. Twist is honored to support Biodesign Challenge in their efforts to continue the dialogue of biotech, design, and innovation. Photo Credits: Shannon Carroll/Vivid Story (Vivid Story) & MICA Biofabrication Lab.

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1

Similar pages

Browse jobs

Funding

Twist Bioscience 10 total rounds

Last Round

Post IPO equity

US$ 250.0M

See more info on crunchbase